HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Clinical trials for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early COVID-19 treatment trial for vulnerable cancer patients halted
Disease control TerminatedThis early-stage study tested whether two immune-stimulating drugs (rintatolimod and interferon) could help cancer patients fight off COVID-19 infections. The trial aimed to find safe doses and see if the treatment reduced the amount of virus in patients. It was designed for adul…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Two-Pronged attack tested against brain tumors
Disease control TerminatedThis early-phase study tested a combination of two drugs, bintrafusp alfa and pimasertib, for patients with cancer that had spread to the brain (brain metastases). The goal was to find a safe dose and see if the combination could help control the brain tumors and help patients li…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Race to tame deadly side effect of promising cancer drugs
Disease control TerminatedThis study aimed to find a better treatment for a serious lung inflammation that can occur as a side effect of certain cancer immunotherapies when standard steroid treatment fails. It tested two different drug combinations (infliximab or intravenous immunoglobulin) in cancer pati…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Targeted drug duo tested for tough blood cancers
Disease control TerminatedThis study tested a combination of two drugs, omacetaxine and venetoclax, for adults with acute myeloid leukemia or myelodysplastic syndrome that has returned or stopped responding to treatment, and who have a specific genetic change called RUNX1. The goal was to find the safest,…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC
-
New care strategies aim to help frail patients survive and thrive after risky transplants
Symptom relief TerminatedThis study tested different supportive care approaches to help older or frail patients with blood diseases recover better after a donor stem cell transplant. Researchers compared symptom-focused care, management of other health conditions, a combination of both, and standard care…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:14 UTC